Keep up to date on the latest news from Jones.
Introducing FlexRx™ Gen 2 and FlexRx™ Reseal providing enhanced efficiency and flexibility for pharmacists. These blister packs streamline the sealing process with raised alignment posts, smart adhesive strips, and cavity perforations. Upgrade to efficient and sustainable adherence solutions today.
Read MoreIn partnership with YouAreUNLTD, a leading voice in healthy aging, we launched a new video and content platform, Mind Your Meds. Together, we are on a mission to raise awareness around the value of medication adherence to empower individuals to take charge of their health.
Read MoreEcoVadis, a globally recognized sustainability ratings provider, awarded Jones Healthcare Group a silver-medal ranking for 2023. This rating demonstrates our continued commitment to the sustainability of our environment and society.
Read MoreWe’re delighted to announce our sponsorship of the Canadian Pharmacists Association (CPhA) Pharmacy Workforce Wellness Initiative, the first national campaign aimed at promoting mental health and resilience within the pharmacy profession in Canada.
Read MoreWILL Employment Solutions presented Jones Healthcare Group with the 2022-2023 WILL Award recognizing a significant contribution to newcomer job seekers through welcoming, innovation, learning and leadership.
Read MoreJones Healthcare Group proudly announces its membership to the Global Self-Care Federation's Charter for Environmentally Sustainable Self-Care. Through this commitment, we aim to minimize environmental impacts while prioritizing health outcomes and product safety.
Read MoreWe’re thrilled to celebrate the 25th anniversary of our Venalink Spain team! As a respected leader in monitored dosage systems (MDS), Venalink became part of Jones Healthcare Group in 2005.
Read MoreJones Healthcare Group is driving positive change through sustainable development, with four new commitments outlined in their latest sustainability report. Discover the progress highlights and targets for 2030.
Read MoreJones Healthcare Group invests in HEIDELBERG's Gallus Labelmaster 440 press to support nutraceutical brands in Canada. The investment is part of the company's $30M capital investment plan to increase production capacity and enhance equipment portfolio.
Read More